Dr. Liu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1810 116th Ave NE
Ste 100
Bellevue, WA 98004Phone+1 425-455-2275Fax+1 425-455-1511
Education & Training
University of Utah HealthResidency, Dermatology, 2000 - 2003
University of California San Francisco School of MedicineFellowship, 1999 - 2000
Tulane UniversityInternship, Internal Medicine, 1998 - 1999
New York University School of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 1999 - Present
WA State Medical License 2004 - 2026
UT State Medical License 2000 - 2006
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia Start of enrollment: 2018 Jul 12
Roles: Principal Investigator, Contact, Study Director
Publications & Presentations
PubMed
- Full Guidelines-From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis an...Warren A James, Angela L Rosenberg, Jashin J Wu, Sylvia Hsu, April Armstrong
Journal of the American Academy of Dermatology. 2024-08-01 - 1 citationsExploring the Clinical Assessment, Guidelines, and Options for the Treatment of Generalized Pustular Psoriasis [Podcast].Eingun James Song, Clive Liu
Clinical, Cosmetic and Investigational Dermatology. 2023-01-01 - 7 citationsBrodalumab to the Rescue: Efficacy and Safety of Brodalumab in Patients with Psoriasis and Prior Exposure or Inadequate Response to Biologics.Alan Menter, April W. Armstrong, Abby S. Van Voorhees, Clive Liu, Abby Jacobson
Dermatology and Therapy. 2020-06-12
Press Mentions
Brodalumab to the Rescue: Efficacy and Safety of Brodalumab in Patients with Psoriasis and Prior Exposure or Inadequate Response to BiologicsJune 12th, 2020
COSENTYX (Secukinumab) for the Ongoing Management of Adult Patients with Moderate to Severe Plaque Psoriasis and Active Psoriatic ArthritisDecember 7th, 2017
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
